Next Gen Diagnostics CEO Paul Rhodes Announces Plan to for NGD’s subsidiary, Next Gen Diagnostics, Israel, Ltd., to Open Lab at Sheba Hospital in Tel Aviv

Next Gen Diagnostics announced that its Israeli subsidiary, Next Gen Diagnostics Israel, Ltd., will open a pathogen sequencing and bioinformatics laboratory in the Laboratory Wing of Sheba Medical Center, the largest medical complex in the Middle East, to provide all hospitals and researchers in Israel access to low cost bacterial whole genome sequencing (WGS) and pathogen bioinformatics, both to support the use of WGS to detect transmission of infection and for diagnostics and antimicrobial resistance (AMR) research.

Previous
Previous

Next Gen Diagnostics CEO Paul Rhodes Announces that Patricia Simner has Joined NGD’s Scientific Advisory Board

Next
Next

Next Gen Diagnostics CEO Paul Rhodes Announces Formation of UK Subsidiary, Next Gen Diagnostics UK, Ltd.